Shuttle Pharmaceuticals Inc (SHPH NASDAQ) stock market data APIs
$1.7535
-0.21(-12%)
as of December 5, 2025
Try our APIs with
free plan!
Shuttle Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to cure cancers. The company is developing Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas; and SP-2-225, a pre-clinical class IIb product candidate that effects on the regulation of the immune system. It is also developing SP-1-303, a pre-clinical selective Class I HDAC for use in the treatment of ER positive breast cancers; and SP-1-161, a HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Prev. Close
1.7535
Open
1.5387
High
1.7721
Low
1.533
52 wk Range
1.26-25.25
Market Cap
2 806 K
Shares Outstanding
1 603 K
EPS
-1.05
Beta
0.563
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Shuttle Pharmaceuticals Inc data using free add-ons & libraries
Get Shuttle Pharmaceuticals Inc Fundamental Data
Shuttle Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -10 902 884
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-13
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Shuttle Pharmaceuticals Inc News
New
Shuttle Pharma Appoints Christopher Cooper As Interim CFO
(RTTNews) - In the SEC filing, Shuttle Pharmaceuticals Holdings, Inc. (SHPH) announced on Friday that Timothy Lorber has resigned as Chief Financial Officer on November 21, 2025. Christopher Cooper, ...
Key deals this week: Kenvue, Warner Bros. Discovery, Adobe, Workday and more
Here's a list of key deals reported across sectors this week: Kenvue (KVUE [https://seekingalpha.com/symbol/KVUE]) rose 3% amid some speculation [https://seekingalpha.com/news/4525104-kenvue-gains-am...
Shuttle Executes LOI with Molecule.ai
GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty p...
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty ph...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
